Borwin Bandelow

Best Publications

• Epidemiology of anxiety disorders in the 21st century.

  Borwin Bandelow;Sophie Michaelis

  2371
  Citations

• Treatment of anxiety disorders.

  Borwin Bandelow;Sophie Michaelis;Dirk Wedekind

  902
  Citations

• Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

  David S. Baldwin;David S. Baldwin;Ian M. Anderson;David J. Nutt;Christer Allgulander

  779
  Citations

• Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

  David S. Baldwin;Ian M. Anderson;David J. Nutt;Borwin Bandelow

  773
  Citations

• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

  Borwin Bandelow;Josef Zohar;Eric Hollander;Siegfried Kasper

  771
  Citations

• Efficacy of treatments for anxiety disorders: a meta-analysis.

  Borwin Bandelow;Markus Reitt;Christian Röver;Sophie Michaelis

  657
  Citations

• Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder

  Andreas Broocks;Borwin Bandelow;Gunda Pekrun;Annette George

  582
  Citations

• Guidelines for the pharmacological treatment of anxiety disorders, obsessive - compulsive disorder and posttraumatic stress disorder in primary care

  Borwin Bandelow;Leo Sher;Robertas Bunevicius;Eric Hollander

  505
  Citations

• Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls.

  Borwin Bandelow;Joana Krause;Dirk Wedekind;Andreas Broocks

  466
  Citations

• Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

  Bandelow B

  453
  Citations

• Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

  Borwin Bandelow;David Baldwin;Marianna Abelli;Blanca Bolea-Alamanac

  371
  Citations

• What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?

  Borwin Bandelow;David S. Baldwin;Ornah T. Dolberg;Henning Friis Andersen

  256
  Citations

• Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder.

  Borwin Bandelow;Aicha Charimo Torrente;Dirk Wedekind;Andreas Broocks

  241
  Citations

• Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders

  Borwin Bandelow;Ulrich Seidler-Brandler;Andreas Becker;Dirk Wedekind

  233
  Citations

• Neuropeptide S receptor gene -- converging evidence for a role in panic disorder.

  Katharina Domschke;Andreas Reif;Heike Weber;Jan Richter

  214
  Citations

• TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies.

  A. Erhardt;L. Czibere;D. Roeske;S. Lucae

  208
  Citations

• Panic and Agoraphobia Scale (PAS).

  Borwin Bandelow

  198
  Citations

• Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder

  Borwin Bandelow;Corinna Späth;Gabriel Álvarez Tichauer;Andreas Broocks

  196
  Citations

• WCA recommendations for the long-term treatment of generalized anxiety disorder.

  Christer Allgulander;Borwin Bandelow;Eric Hollander;Stuart A. Montgomery

  183
  Citations

• Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.

  Borwin Bandelow;Guy Chouinard;Julio Bobes;Antti Ahokas

  176
  Citations